Only show
results from:

Sort results by:

Display preferences
339 results sorted by relevancy Results per page:
AMAG Pharmaceuticals, Inc. Announces Update on Sinerem(TM) in Europe.
Business Wire; Dec 13, 2007; 700+ Words ...Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced...Combidex is AMAG Pharmaceutical's investigational...lymph nodes. AMAG Pharmaceuticals, Inc. has granted...In March 2005, AMAG Pharmaceuticals...
AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China.
PR Newswire; May 27, 2008; 700+ Words ...FirstCall/ -- AMAG Pharmaceuticals, Inc. and 3SBio, Inc...please contact: AMAG Pharmaceuticals, Inc. Kristen Galfetti...amagpharma.com 3SBio, Inc. Mahmoud Siddig Tel...rafferty.com CONTACT: AMAG Pharmaceuticals...
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2009.(Financial report)
Business Wire; Oct 29, 2009; 700+ Words ...LEXINGTON, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical...2009. About AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. is a biopharmaceutical...cardiovascular disease. AMAG recently received...
Stock Profiler.US Profiles Vivakor, Inc. & AMAG Pharmaceuticals, Inc.
M2 Presswire; Oct 7, 2009; 700+ Words ...com: Stock Profiler.US Profiles Vivakor, Inc. & AMAG Pharmaceuticals, Inc.(C)1994-2009 M2 COMMUNICATIONS RDATE...York, NY =- Vivakor, Inc. (OTCBB: VIVK); AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) Stock...
AMAG Pharmaceuticals, Inc. Reports on Progress Toward Commercialization and Discusses Key Activities for 2008 at 26th Annual JPMorgan Healthcare Conference.(Conference news)
Business Wire; Jan 8, 2008; 700+ Words CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian J.G. Pereira...from normal lymph nodes. In March 2005, AMAG Pharmaceuticals, Inc. received an approvable letter from the...
AMAG Pharmaceuticals, Inc. to Present at the Canaccord Adams 29th Annual Global Growth Conference.(Conference news)
Business Wire; Aug 4, 2009; 539 Words LEXINGTON, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian J.G. Pereira...will be archived on the AMAG Pharmaceuticals, Inc. website until August 25, 2009. About AMAG...
AMAG Pharmaceuticals, Inc. Submits New Drug Application to FDA for Ferumoxytol in Chronic Kidney Disease Patients.
Business Wire; Dec 19, 2007; 700+ Words CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it has submitted a New...MD, President and CEO, AMAG Pharmaceuticals, Inc. "We are committed to bringing novel therapies...
AMAG Pharmaceuticals, Inc. to Participate in the Lazard Capital Markets 6th Annual Healthcare Conference.(Conference news)
Business Wire; Nov 12, 2009; 521 Words LEXINGTON, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that David Arkowitz, Executive...will be archived on the AMAG Pharmaceuticals, Inc. website until December 2, 2009. About AMAG...
Global Market Perspective Review for Amag Pharmaceuticals Inc.
M2 Presswire; Jan 31, 2008; 700+ Words ...Market Perspective Review for Amag Pharmaceuticals Inc(C)1994-2008 M2 COMMUNICATIONS...resumed our progressive review of Amag Pharmaceuticals Inc (NASDAQ...lymph nodes. In March 2005, AMAG Pharmaceuticals, Inc. received an approvable letter...
AMAG Pharmaceuticals, Inc. to Present at Two Upcoming Healthcare Conferences.(Conference news)
Business Wire; Jan 23, 2008; 700+ Words ...CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that...Merrill Lynch Global Pharmaceutical, Biotechnology and Medical...will be archived on the AMAG Pharmaceuticals, Inc. web site for approximately...
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter Ended September 30, 2007.
Business Wire; Oct 25, 2007; 700+ Words CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company that utilizes...Chief Executive Officer of AMAG Pharmaceuticals, Inc. "We are delighted to have had eight abstracts...
AMAG Pharmaceuticals, Inc. Announces Appointment of Robert M. Brenner, M.D. as Senior Vice President of Medical Affairs.
Business Wire; May 19, 2008; 700+ Words CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the appointment of Robert M...Global Renal Anemia Program Area Leader at Amgen Inc. Dr. Brenner will be responsible for the Company...
AMAG Pharmaceuticals, Inc. to Present at CANACCORD Adams 27th Annual Global Growth Conference.
Business Wire; Jul 31, 2007; 573 Words CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it will participate in...President and CEO of AMAG Pharmaceuticals, Inc. will present an overview of the company on August...
AMAG Pharmaceuticals, Inc. Announces Eight Abstracts on Ferumoxytol to Be Presented at Upcoming American Society of Nephrology Meeting.
Business Wire; Oct 10, 2007; 700+ Words CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company that utilizes...disease patients. About AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. is a biopharmaceutical...
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter Ended March 31, 2008.
Business Wire; Apr 25, 2008; 700+ Words CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), a biopharmaceutical company that utilizes...Chief Executive Officer of AMAG Pharmaceuticals, Inc. "Our New Drug Application for ferumoxytol is...
AMAG Pharmaceuticals, Inc. to Present at the 26th Annual JPMorgan Healthcare Conference.(Conference news)
Business Wire; Dec 10, 2007; 634 Words CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian J.G. Pereira, MD, President and CEO of AMAG Pharmaceuticals, Inc. will present an overview of the Company at the...
AMAG Pharmaceuticals, Inc. Announces Data Presentations at the American Society of Nephrology (ASN) Renal Week Meeting.
Business Wire; Oct 7, 2009; 694 Words LEXINGTON, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that three abstracts have been...October 31, 2009 About AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. is a biopharmaceutical...
AMAG Pharmaceuticals, Inc. Announces Presentation of Positive Results from Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapeutic in the Elderly at the American Society of Hematology Annual Meeting.
Business Wire; Dec 9, 2007; 700+ Words CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company that utilizes...MD, President and CEO of AMAG Pharmaceuticals Inc. "We believe that these data, combined with...
AMAG Pharmaceuticals, Inc. to Host Quarterly Earnings Conference Call to Discuss September 30, 2007 Results.
Business Wire; Oct 11, 2007; 700+ Words CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report financial results...About AMAG Pharmaceuticals AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes...
AMAG Pharmaceuticals, Inc. Announces Presentation of Positive Results from Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapy in Kidney Transplant Recipients at the American Transplant Congress.
Business Wire; May 31, 2008; 700+ Words CAMBRIDGE, Mass. -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company that utilizes...MD, President and CEO of AMAG Pharmaceuticals Inc. "The treatment of iron deficiency anemia with...
339 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives